Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARTLNYSEARCA:HDIVNYSEARCA:ROOF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARTLArtelo Biosciences$1.04+1.0%$0.98$0.82▼$1.59$3.41M1.17134,072 shs23,155 shsHDIVQRAFT AI-Enhanced U.S. High Dividend ETF$31.38$31.38$27.51▼$32.79$2.51MN/A977 shsN/AROOFNYLI CBRE NextGen Real Estate ETF$20.75-0.2%$20.75$18.43▼$22.69$153.55M0.9544,034 shs14,300 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARTLArtelo Biosciences+0.97%+9.04%+8.79%-11.86%-22.49%HDIVQRAFT AI-Enhanced U.S. High Dividend ETF0.00%0.00%0.00%0.00%0.00%ROOFNYLI CBRE NextGen Real Estate ETF0.00%0.00%0.00%0.00%+11.74%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARTLArtelo Biosciences2.3916 of 5 stars3.82.00.00.02.70.01.3HDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/AN/AN/AN/AN/AN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARTLArtelo Biosciences 3.50Strong Buy$5.50428.85% UpsideHDIVQRAFT AI-Enhanced U.S. High Dividend ETF 0.00N/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETF 2.68Moderate Buy$20.75N/ACurrent Analyst Ratings BreakdownLatest HDIV, ROOF, BRLA, and ARTL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/2/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.003/4/2025ARTLArtelo BiosciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.00 ➝ $5.002/27/2025ARTLArtelo BiosciencesD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$6.00 ➝ $6.00(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARTLArtelo BiosciencesN/AN/AN/AN/A$4.12 per shareN/AHDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/AN/AN/AN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARTLArtelo Biosciences-$9.29M-$3.05N/AN/AN/AN/A-104.59%-94.06%5/12/2025 (Estimated)HDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/AN/A0.00∞N/AN/AN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/A26.87∞N/AN/AN/AN/AN/ALatest HDIV, ROOF, BRLA, and ARTL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025ARTLArtelo Biosciences-$0.13N/AN/AN/AN/AN/A3/3/2025Q4 2024ARTLArtelo Biosciences-$0.74-$1.17-$0.43-$1.17N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARTLArtelo BiosciencesN/AN/AN/AN/AN/AHDIVQRAFT AI-Enhanced U.S. High Dividend ETF$0.752.39%N/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETF$0.572.75%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARTLArtelo BiosciencesN/A7.157.15HDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/AN/AN/AROOFNYLI CBRE NextGen Real Estate ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARTLArtelo Biosciences0.87%HDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/AROOFNYLI CBRE NextGen Real Estate ETFN/AInsider OwnershipCompanyInsider OwnershipARTLArtelo Biosciences0.83%HDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/AROOFNYLI CBRE NextGen Real Estate ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARTLArtelo Biosciences53.28 million3.20 millionNot OptionableHDIVQRAFT AI-Enhanced U.S. High Dividend ETFN/A80,000N/ANot OptionableROOFNYLI CBRE NextGen Real Estate ETFN/A7.40 millionN/ANot OptionableHDIV, ROOF, BRLA, and ARTL HeadlinesRecent News About These CompaniesWhen (ROOF) Moves Investors should ListenOctober 6, 2024 | news.stocktradersdaily.comROOF NYLI CBRE NextGen Real Estate ETFSeptember 22, 2024 | seekingalpha.comWhen the Price of (ROOF) Talks, People ListenAugust 7, 2024 | news.stocktradersdaily.comVY® CBRE Real Estate AAugust 3, 2024 | morningstar.comMainStay CBRE Real Estate IJuly 31, 2024 | morningstar.comTrend Tracker for (ROOF)July 28, 2024 | news.stocktradersdaily.comMainStay CBRE Real Estate AJuly 25, 2024 | morningstar.comMainStay CBRE Real Estate R6July 24, 2024 | morningstar.comVY® CBRE Global Real Estate IJuly 19, 2024 | morningstar.comMainStay CBRE Real Estate Fund;IMay 25, 2024 | wsj.comROOF IQ CBRE NextGen Real Estate ETFFebruary 16, 2024 | seekingalpha.comIndexIQ’S IQ U.S. Real Estate Small Cap ETF Completes Transition to Track IQ CBRE NextGen Real Estate Index (Ticker: ROOF)September 1, 2022 | finance.yahoo.comIQ U.S. Real Estate Small Cap ETF (ROOF)August 30, 2022 | finance.yahoo.comBuffer ETFs are beating the market in 2022 and delivering protection for patient investorsAugust 14, 2022 | cnbc.comCarter's's Return On Invested Capital InsightsAugust 1, 2022 | msn.comUS small caps attract bargain-hunting investors with cheap valuationsJuly 31, 2022 | msn.comNorthstar Announces 2022 AGSM ResultsJuly 29, 2022 | finance.yahoo.comFifth Wall invests $500M to decarbonize the real estate industryJuly 22, 2022 | realtybiznews.comLarge-Cap US E&P Oil Stocks Are Dirt Cheap and Most Pay Huge Dependable DividendsJuly 19, 2022 | msn.comFort Worth-based Fort Capital acquires Class B industrial portfolio in EulessJuly 13, 2022 | bizjournals.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?4 Dividend Growth Stocks the Trade Tariffs Can’t TouchBy Thomas Hughes | April 7, 2025View 4 Dividend Growth Stocks the Trade Tariffs Can’t TouchAT&T and Verizon: 2 Telecom Titans for a Tariff-Proof PlayBy Jeffrey Neal Johnson | March 31, 2025View AT&T and Verizon: 2 Telecom Titans for a Tariff-Proof PlayWith a 60%+ Upside, There’s Plenty to Love About LovesacBy Jea Yu | April 20, 2025View With a 60%+ Upside, There’s Plenty to Love About LovesacTariff-Proof Stocks: 3 Big Bargains With Huge Upside PotentialBy Gabriel Osorio-Mazilli | April 8, 2025View Tariff-Proof Stocks: 3 Big Bargains With Huge Upside PotentialHDIV, ROOF, BRLA, and ARTL Company DescriptionsArtelo Biosciences NASDAQ:ARTL$1.04 +0.01 (+0.97%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$1.02 -0.02 (-1.92%) As of 04/25/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.QRAFT AI-Enhanced U.S. High Dividend ETF NYSEARCA:HDIV$31.38 0.00 (0.00%) As of 02/3/2023NYLI CBRE NextGen Real Estate ETF NYSEARCA:ROOF$20.75 -0.05 (-0.24%) As of 11/20/2024The IQ U.S. Real Estate Small Cap ETF (ROOF) is an exchange-traded fund that is based on the IQ CBRE NextGen Real Estate index. The fund tracks a tier-weighted index of developed market companies classified under real estate sectors that are expected to benefit from trends affecting property sectors in the global economy. ROOF was launched on Jun 14, 2011 and is managed by IndexIQ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
